Related Experiment Video
Updated: May 26, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
Published on: February 28, 2025
Management of choledochal cyst with portal hypertension
S S Saluja1, P K Mishra, B C Sharma
1Department of Gastrointestinal Surgery, GB Pant Hospital, 1 Jawaharlal Nehru Marg, New Delhi 110002, India. sundeepsaluja@yahoo.co.in
Insights
Portal hypertension (PHT) is a rare complication of choledochal cysts. Management varies based on the cause, with surgical options for secondary biliary cirrhosis and conservative or endoscopic approaches for other etiologies.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Gastroenterology
Background:
- Portal hypertension (PHT) is an infrequent complication of choledochal cysts.
- Management strategies for PHT in choledochal cyst patients are not well-defined due to low incidence and varied causes.
Observation:
- Three cases of type IVa choledochal cysts with PHT are presented.
- Causes of PHT included secondary biliary cirrhosis (SBC) in two patients and alcoholic liver disease in one.
- Clinical manifestations encompassed jaundice, gastrointestinal bleeding, and ascites.
Findings:
- One patient with SBC underwent successful surgical excision with hepaticojejunostomy.
- Another patient with cholangitis received endoscopic retrograde cholangiopancreatography (ERCP) stenting.
- The patient with alcoholic liver disease was managed conservatively for seven years, ultimately succumbing to liver failure.
Implications:
- Management of choledochal cysts with PHT should be tailored to the severity of liver disease.
- Surgical intervention is recommended for patients with SBC.
- Endoscopic stenting may serve as a temporary measure for high-risk individuals.
Abstract:
Portal hypertension (PHT) is a rare complication associated with choledochal cysts. Management issues of PHT patients are inadequately addressed, as its incidence is low and underlying causes variable. We report three cases of choledochal cyst with PHT. All patients had type IVa choledochal cysts, and the causes of PHT were secondary biliary cirrhosis (SBC) (two cases) and alcoholic liver disease (one case). Clinical presentation included jaundice, gastrointestinal bleeding and ascites. One patient with SBC successfully underwent excision with Rouxen-Y hepaticojejunostomy, while the patient with cholangitis was managed with endoscopic retrograde cholangiopancreatography stenting. The last patient with alcoholic liver disease was managed conservatively for seven years and died of liver failure. Management of choledochal cysts depends on the severity of liver disease in cases of cirrhosis of unrelated cause, while those with SBC should be considered for surgical management. Endoscopic stenting may be considered as a temporary measure in high-risk cases.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Portal Hypertension
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Cholecystitis